Clinical Evaluation of the Ultrasound-Guided Retroclavicular Brachial Plexus Block

Sponsor
Brigham and Women's Hospital (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01605929
Collaborator
(none)
0
1
1
14
0

Study Details

Study Description

Brief Summary

The primary objective of this prospective, descriptive study is to evaluate the success rate of the retroclavicular brachial plexus block and catheter placement in 60 adult patients undergoing hand, wrist, or forearm surgery. The investigators will also evaluate any difficulties performing the procedure, the onset time and distribution of the block, incidence of adverse events, and patient's acceptance of the block.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Retroclavicular Brachial Plexus Block and Catheter Insertion
N/A

Detailed Description

Nerve blocks are used by anesthesiologists as methods of pain control or to allow for painless surgery on a limb, rendering a general anesthetic for surgery unnecessary. Local anesthetic medication is injected through a needle next to a nerve, often using an ultrasound machine to visualize both the needle and nerve simultaneously. A catheter, a small plastic tube, can be inserted next to the nerve in order to provide pain relief for hours or days after surgery.

The nerves that provide sensation to the forearm, wrist and hand are the radial, median, ulnar, musculocutaneous and medial nerve of the forearm. These nerves originate from a network of nerve fibers that exit the spinal cord at the level of the neck. They are tightly bundled together, forming the brachial plexus, from the neck to just above the axilla, providing the anesthesiologist with many locations to perform a nerve block. One such block, known as the infraclavicular block, approaches the nerves just beneath the clavicle and has been performed for decades.

This study aims to examine a new technique to block the brachial plexus, performed at a similar level as the infraclavicular brachial plexus nerve block. The ultrasound-guided retroclavicular brachial plexus block has the potential advantages of being easier to perform, more successful, less painful for the patient, and a better pathway for catheter placement. It differs from the infraclavicular nerve block in that the needle is inserted above the clavicle rather than below it. In addition, it will allow the anesthesiologist to have another approach to the brachial plexus, which can be utilized if patients cannot have an infraclavicular block or any other brachial plexus block due to anatomical changes, or infection at the sight.

The retroclavicular brachial plexus block was first used in two patients at Brigham and Women's Hospital in whom the infraclavicular approach was contraindicated due to anatomical changes after surgery or trauma. This procedure has been found to be a reliable way to perform a brachial plexus nerve block and has become a routine procedure at Brigham and Women's Hospital for hand or forearm surgery over the past three years.

In reviewing the literature, a similar procedure was introduced by Hebbard and Royse in 2007, but no patient data was reported. By assessing the procedure in a prospective study, the investigators will be able to describe the technique, the success rate and any complications in the literature to allow other anesthesiologists to potentially incorporate this block into their repertoire.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Clinical Evaluation of the Ultrasound-Guided Retroclavicular Brachial Plexus Block
Study Start Date :
Jul 1, 2012
Anticipated Primary Completion Date :
Sep 1, 2013
Anticipated Study Completion Date :
Sep 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Retroclavicular Brachial Plexus Block

Procedure: Retroclavicular Brachial Plexus Block and Catheter Insertion
A Sonosite ultrasound machine will be used to visualize the nerve and needle simultaneously. A Braun 18 g 4 inch Touhy needle with markings will be inserted into the skin and advanced toward the nerve. Once the optimal location is determined under ultrasound visualization, the local anesthetic, mepivacaine, will be injected beside the nerves. The dose of drug will be mepivacaine 1.5%, 0.5 cc/kg (with a minimum 30 cc and maximum of 50 cc.) A Braun 20 g closed tip polyamide catheter will be inserted next to the nerve and left in place to allow for additional medication to be given postoperatively.
Other Names:
  • Carbocaine
  • Outcome Measures

    Primary Outcome Measures

    1. Success Rate [20 minutes after nerve block completed]

      Success rate will be defined as the number of patients with anesthesia or analgesia in all five nerves below the elbow (median, ulnar, radial, musculocutaneous, median nerve of the forearm).

    Secondary Outcome Measures

    1. Motor Function [20 minutes after nerve block completed]

      Strength of muscles innervated by radial, median, ulnar, musculocutaneous, and axillary nerves

    2. Complication of Procedure [From nerve block completion to patient's arrival in PACU, with an expected average duration of 3 hours]

      Pneumothorax, Horner's syndrome, Symptomatic phrenic nerve palsy, Local anesthesia toxicity, block failure, catheter dislodgement.

    3. Followup of Block Resolution [48-96 hours post Retroclavicular Brachial Plexus Block]

      Pain/Bruising/Infection at injection site, Unresolved paresthesias/weakness of operative arm, Preferences for Future Surgery

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • undergoing surgery of hand, wrist or forearm

    • American Society of Anesthesiologists (ASA) physical status of I-II

    • age greater than 18 years

    • ability to provide written informed consent

    Exclusion Criteria:
    • clinically significant coagulopathy

    • infection at the injection site

    • abnormal anatomy at the block site

    • allergy to amide anesthetics

    • severe pulmonary pathology

    • pre-existing motor or sensory deficits in the operative limb

    • pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Brigham and Women's Hospital Boston Massachusetts United States 02115

    Sponsors and Collaborators

    • Brigham and Women's Hospital

    Investigators

    • Principal Investigator: Kamen Vlassakov, MD, Brigham and Women's Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Kamen Vlassakov, Director of the Division of Regional and Orthopedic Anesthesia, Brigham and Women's Hospital
    ClinicalTrials.gov Identifier:
    NCT01605929
    Other Study ID Numbers:
    • 2012P000874
    First Posted:
    May 25, 2012
    Last Update Posted:
    Dec 7, 2015
    Last Verified:
    Dec 1, 2015
    Keywords provided by Kamen Vlassakov, Director of the Division of Regional and Orthopedic Anesthesia, Brigham and Women's Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 7, 2015